Revolution Medicines, Inc. (RVMD) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RVMD Hot Sheet
Join SI Premium – FREE
Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q2 EPS of ($0.81), $0.04 worse than the analyst estimate of ($0.77).
For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- SPS Commerce hires Morgan Stanley, explores sale - Reuters
- Italy's Meloni seeks to normalize US relations after Trump spat
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
